These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 26982103)
41. Efficacy of tigecycline for the treatment of complicated intra-abdominal infections in real-life clinical practice from five European observational studies. Eckmann C; Montravers P; Bassetti M; Bodmann KF; Heizmann WR; Sánchez García M; Guirao X; Capparella MR; Simoneau D; Dupont H J Antimicrob Chemother; 2013 Jul; 68 Suppl 2():ii25-35. PubMed ID: 23772043 [TBL] [Abstract][Full Text] [Related]
43. Tigecycline: an antibiotic for the twenty-first century. Dryden M J Antimicrob Chemother; 2013 Jul; 68 Suppl 2():ii3-4. PubMed ID: 23772044 [TBL] [Abstract][Full Text] [Related]
44. Therapeutic applications of tigecycline in the management of complicated skin and skin structure infections. Grolman DC Int J Infect Dis; 2007 May; 11 Suppl 1():S7-15. PubMed ID: 17603950 [TBL] [Abstract][Full Text] [Related]
45. In vitro activity of tigecycline against isolates from patients enrolled in phase 3 clinical trials of treatment for complicated skin and skin-structure infections and complicated intra-abdominal infections. Bradford PA; Weaver-Sands DT; Petersen PJ Clin Infect Dis; 2005 Sep; 41 Suppl 5():S315-32. PubMed ID: 16080070 [TBL] [Abstract][Full Text] [Related]
46. The efficacy and safety of tigecycline for the treatment of bloodstream infections: a systematic review and meta-analysis. Wang J; Pan Y; Shen J; Xu Y Ann Clin Microbiol Antimicrob; 2017 Apr; 16(1):24. PubMed ID: 28381268 [TBL] [Abstract][Full Text] [Related]
47. Efficacy of tigecycline for the treatment of complicated skin and soft-tissue infections in real-life clinical practice from five European observational studies. Montravers P; Bassetti M; Dupont H; Eckmann C; Heizmann WR; Guirao X; García MS; Capparella MR; Simoneau D; Bodmann KF J Antimicrob Chemother; 2013 Jul; 68 Suppl 2():ii15-24. PubMed ID: 23772042 [TBL] [Abstract][Full Text] [Related]
48. Tigecycline in combination with other antimicrobials: a review of in vitro, animal and case report studies. Entenza JM; Moreillon P Int J Antimicrob Agents; 2009 Jul; 34(1):8.e1-9. PubMed ID: 19162449 [TBL] [Abstract][Full Text] [Related]
49. Tigecycline: place in therapy and important considerations. Garrelts JC; Schroeder T Am J Health Syst Pharm; 2006 Jul; 63(13):1233. PubMed ID: 16790574 [No Abstract] [Full Text] [Related]
50. Multidrug-resistant Gram-negative bacteria: how to treat and for how long. Giamarellou H Int J Antimicrob Agents; 2010 Dec; 36 Suppl 2():S50-4. PubMed ID: 21129924 [TBL] [Abstract][Full Text] [Related]
52. In vitro synergistic activity of tigecycline and colistin against XDR-Acinetobacter baumannii. Dizbay M; Tozlu DK; Cirak MY; Isik Y; Ozdemir K; Arman D J Antibiot (Tokyo); 2010 Feb; 63(2):51-3. PubMed ID: 19942947 [TBL] [Abstract][Full Text] [Related]
53. Efficacy of tigecycline alone and with rifampin in foreign-body infection by methicillin-resistant Staphylococcus aureus. Garrigós C; Murillo O; Euba G; Verdaguer R; Tubau F; Cabellos C; Cabo J; Ariza J J Infect; 2011 Sep; 63(3):229-35. PubMed ID: 21763722 [TBL] [Abstract][Full Text] [Related]
54. Activity of Colistin in Combination with Meropenem, Tigecycline, Fosfomycin, Fusidic Acid, Rifampin or Sulbactam against Extensively Drug-Resistant Acinetobacter baumannii in a Murine Thigh-Infection Model. Fan B; Guan J; Wang X; Cong Y PLoS One; 2016; 11(6):e0157757. PubMed ID: 27315107 [TBL] [Abstract][Full Text] [Related]
56. In vitro Activity of Colistin in Combination with Tigecycline against Carbapenem-Resistant Acinetobacter baumannii Strains Isolated from Patients with Ventilator-Associated Pneumonia. Cikman A; Gulhan B; Aydin M; Ceylan MR; Parlak M; Karakecili F; Karagoz A Int J Med Sci; 2015; 12(9):695-700. PubMed ID: 26392806 [TBL] [Abstract][Full Text] [Related]
57. Resistance mechanisms and epidemiology of multiresistant pathogens in Europe and efficacy of tigecycline in observational studies. Heizmann WR; Dupont H; Montravers P; Guirao X; Eckmann C; Bassetti M; García MS; Capparella MR; Simoneau D; Bodmann KF J Antimicrob Chemother; 2013 Jul; 68 Suppl 2():ii45-55. PubMed ID: 23772046 [TBL] [Abstract][Full Text] [Related]
58. Use of tigecycline in critically ill patients with serious nosocomial intra-abdominal infections. Maseda E; Denis SE; Riquelme A; Gilsanz F Rev Esp Quimioter; 2013 Mar; 26(1):56-63. PubMed ID: 23546465 [TBL] [Abstract][Full Text] [Related]